High risk patients undergoing prophylactic intraaortic balloon counterpulsation compared with standard care without intraaortic balloon pump: A feasibility study

Royal Perth Hospital0 个研究点目标入组 40 人开始时间: 2014年7月4日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•1.The patient is listed for cardiac surgery that includes CABG
•2.The treating surgical team considers prophylactic IABC may be of benefit
•Severely impaired left ventricular function of any cause
•Recent or ongoing myocardial ischaemia+
•Critical coronary artery stenosis
•+myocardial ischaemia defined by pain at rest, requirement for IV GTN or heparin, or elevated troponin.

•1.Patient age <18 years
•2.Patient has an IABC, ventricular assist device or ECMO circuit in situ
•3.IABC placement is planned for an immediate therapeutic indication (e.g. cardiogenic shock, severe mitral regurgitation)
•4.Absolute contraindication to IABC
•a.Severe bilateral lower limb peripheral vascular disease or bilateral femoral arterial grafting
•b.Moderate or severe aortic regurgitation
•c.Abdominal or thoracic aortic aneurysm, severe calcification or dissection
•d.Infection overlying bilateral femoral arteries
•5.Treating clinician deems enrollment is not in the best interest of the patient
•6.Death is imminent and inevitable
•7.Weight <40kg
•8.Patient is highly unlikely to be contactable at 6 months for follow up

发起方